Poultry Vaccines Market
Poultry Vaccines Market Size and Share Forecast Outlook 2026 to 2036
Poultry vaccines market is projected to grow from USD 7.4 billion in 2026 to USD 16.6 billion by 2036, at a CAGR of 8.4%. Live attenuated vaccines will dominate with a 39.9% market share, while newcastle disease will lead the application segment with a 26.6% share.
FREE CustomizationPoultry Vaccines Market Forecast and Outlook 2026 to 2036
The global poultry vaccines market is projected to grow from USD 7.40 billion in 2026 to USD 16.61 billion by 2036, progressing at a CAGR of 8.4%. This sustained expansion is driven by the relentless intensification of global poultry production and the ever-present threat of high-impact avian diseases.
Key Takeaways from the Poultry Vaccines Market
- Market Value for 2026: USD 7.40 Billion
- Market Value for 2036: USD 16.61 Billion
- Forecast CAGR 2026 to 2036: 8.4%
- Leading Product Segment (2026): Live Attenuated Vaccines (39.9%)
- Leading Application Segment (2026): Newcastle Disease (26.6%)
- Leading End-User Segment (2026): Integrated Poultry Farms (49.4%)
- Key Growth Countries: India (11.1% CAGR), China (10.0% CAGR), Brazil (9.7% CAGR), USA (8.6% CAGR), Germany (8.5% CAGR), UK (8.5% CAGR), France (8.4% CAGR)
- Key Players in the Market: Zoetis Inc., Boehringer Ingelheim Animal Health, Ceva Santé Animale, Elanco Animal Health, Phibro Animal Health Corporation
The sector's evolution is marked by a strategic shift from routine disease control toward safeguarding food security and international trade. Outbreaks of highly pathogenic avian influenza continue to act as a potent catalyst for vaccine adoption and innovation worldwide.
A dominant trend is the accelerated development and deployment of recombinant vector vaccines. These next-generation products offer advantages such as the ability to differentiate infected from vaccinated animals (DIVA strategy) and protection against multiple pathogens with a single dose.
The integration of automated in-ovo vaccination technology in large-scale hatcheries is becoming standard, enhancing efficacy and enabling the vaccination of billions of chicks annually. This technological progression underscores the industry's move towards precision preventative health.
Metric
| Metric | Value |
|---|---|
| Market Value (2026) | USD 7.40 Billion |
| Market Forecast Value (2036) | USD 16.61 Billion |
| Forecast CAGR 2026 to 2036 | 8.4% |
Category
| Category | Segments |
|---|---|
| Product | Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines |
| Application | Newcastle Disease, Avian Influenza, Infectious Bursal Disease, Others |
| End User | Integrated Poultry Farms, Commercial Hatcheries, Veterinary Service Providers |
| Region | North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa |
Segmental Analysis
By Product, Which Segment Retains Dominance Due to Cost-Effectiveness and Robust Immunity?
Live attenuated vaccines command a leading 39.9% share. Their continued dominance is rooted in their ability to induce strong, long-lasting cellular and humoral immunity at a relatively low cost.
They are the backbone of vaccination programs against ubiquitous diseases like Newcastle Disease and Infectious Bronchitis. Despite the rise of newer technologies, their proven efficacy and ease of mass administration via drinking water or spray ensure their central role in global poultry health.
By Application, Which Disease Represents the Unwavering Core of Global Vaccination Programs?
Newcastle Disease constitutes the primary application segment at 26.6%. Its devastating potential for causing near-total flock mortality makes vaccination a universal non-negotiable in commercial production.
The disease's endemic presence in many regions mandates lifelong, multi-dose vaccination schedules, creating consistent, high-volume demand that forms the stable foundation of the entire poultry vaccines market.
By End User, Which Group Exercises Centralized Control Over Vaccine Procurement and Protocols?
Integrated poultry farms form the dominant end-user segment at 49.4%. These vertically coordinated operations, which control birds from hatchery to processing, implement standardized, company-wide vaccination protocols to protect their integrated assets.
Their scale allows for bulk procurement, dedicated veterinary oversight, and the adoption of advanced technologies like in-ovo vaccination, making them the most influential buyers.
What are the Principal Drivers, Constraints, and Evolving Dynamics of the Poultry Vaccines Landscape?
| Factor | Market Influence |
|---|---|
| Persistent Threat of Zoonotic and Trade-Disrupting Diseases | Continuous outbreaks of Avian Influenza, a zoonotic and trade-limiting disease, compel mandatory vaccination in an increasing number of countries, directly fueling market growth and R&D investment. |
| High Logistics and Cold Chain Requirements for Biologicals | Maintaining the efficacy of vaccines requires an unbroken cold chain from manufacturer to farm, adding significant cost and complexity, particularly in emerging markets with underdeveloped infrastructure. |
| Expansion in Emerging Economies with Growing Meat Consumption | Rising per-capita poultry consumption in Asia, Africa, and Latin America drives the expansion of commercial production, creating a vast new base for routine vaccination programs. |
| Precision Vaccinology and Tailored Program Design | Moving beyond one-size-fits-all, the trend is toward using diagnostics and farm data to design customized vaccination schedules, optimizing timing, route, and vaccine strain for specific pathogen challenges. |
Analysis of the Poultry Vaccines Market by Key Countries
| Country | CAGR 2026 to 2036 |
|---|---|
| India | 11.1% |
| China | 10.0% |
| Brazil | 9.7% |
| USA | 8.6% |
| Germany | 8.5% |
| UK | 8.5% |
| France | 8.4% |
Is the USA's Market Strategy Pivoting Towards Preemptive HPAI Vaccination?
The USA’s 8.6% CAGR is undergoing a potential strategic shift due to unprecedented HPAI losses. While traditionally reliant on culling, serious consideration of preventative vaccination is gaining traction. This would dramatically alter the poultry vaccines landscape, creating massive demand for federally approved DIVA-compliant vaccines and establishing new national biosecurity protocols.
Does Brazil's Status as a Top Global Exporter Dictate a Zero-Tolerance Vaccine Policy?
Brazil’s 9.7% CAGR is inextricably linked to its export dominance. To maintain access to critical markets, the country enforces one of the world's most rigorous and mandatory vaccination regimes, particularly for Newcastle Disease. Growth is fueled by the need to protect its export revenue, making vaccine coverage and efficacy a matter of national economic security.
Can China's Pursuit of Agri-Tech Self-Sufficiency Extend to Vaccine Sovereignty?
China’s 10.0% CAGR is propelled by its drive for self-sufficiency in core agricultural technologies. The poultry vaccines market is characterized by massive domestic production capacity and rapid development of novel vaccines, including for HPAI, reducing reliance on imports and positioning China as a future exporter of affordable vaccines to the Global South.
Will India's Explosive Layer and Broiler Sector Growth Outpace Vaccine Supply Chains?
India’s leading 11.1% CAGR is driven by its rapidly modernizing and expanding poultry sector, now one of the world's largest. The primary challenge for the poultry vaccines market is ensuring cold chain integrity and veterinary outreach can keep pace with the geographical spread and intensification of production, making last-mile delivery a key growth bottleneck.
Are Germany and the UK's Markets Becoming Laboratories for Sustainable Precision Vaccination?
Germany’s and the UK’s 8.5% CAGRs reflect advanced markets focused on sustainability. Research and adoption center on optimizing vaccine protocols to minimize resource use and animal stress. This includes precise application technologies and leveraging immunity from parent flocks to reduce early chick vaccinations, aligning productivity with heightened welfare standards.
Does France's Diverse Poultry Sector Demand Equally Diverse Vaccination Strategies?
France’s 8.4% CAGR must cater to a highly diversified sector ranging from intensive broiler production to label-rouge (free-range) and waterfowl systems. The poultry vaccines market requires a flexible portfolio, with strategies varying from intensive in-ovo programs for standard broilers to tailored schedules for longer-living, outdoor birds facing different disease pressures.
Competitive Landscape of the Poultry Vaccines Market
The competitive landscape is highly consolidated, dominated by a few multinational animal health corporations with the capital for intensive R&D and global distribution. These leaders compete through extensive vaccine portfolios covering all major diseases and offering combination products for simplified administration. A key battleground is the development of effective, DIVA-compliant vaccines for Avian Influenza, a segment with immense regulatory and commercial stakes.
Competition also focuses on technical service and integration. Leading firms provide more than vaccines; they offer comprehensive vaccination program consulting, hatchery automation equipment, and diagnostic support. Success hinges on forming deep partnerships with integrated poultry producers, embedding their products and protocols into the core of the client's biosecurity operations.
Key Players in the Poultry Vaccines Market
- Zoetis Inc.
- Boehringer Ingelheim Animal Health
- Ceva Santé Animale
- Elanco Animal Health
- Phibro Animal Health Corporation
- Others
Scope of Report
| Items | Metrics |
|---|---|
| Quantitative Units | USD Billion |
| Product | Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines |
| Application | Newcastle Disease, Avian Influenza, Infectious Bursal Disease, Others |
| End User | Integrated Poultry Farms, Commercial Hatcheries, Veterinary Service Providers |
| Key Countries | India, China, Brazil, USA, Germany, France, UK |
| Key Companies | Zoetis, Boehringer Ingelheim, Ceva, Elanco, Phibro, Others |
| Additional Analysis | Efficacy comparison of different vaccine platforms against evolving pathogen strains; economic analysis of vaccination ROI across production systems; impact of maternal immunity on vaccine schedule design; challenges of vaccine delivery in hot/humid climates. |
Market by Segments
-
Product :
- Live Attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
-
Application :
- Newcastle Disease
- Avian Influenza
- Infectious Bursal Disease
- Others
-
End User :
- Integrated Poultry Farms
- Commercial Hatcheries
- Veterinary Service Providers
-
Region :
-
North America
- USA
- Canada
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
-
Western Europe
- Germany
- France
- UK
- Italy
- Spain
- BENELUX
- Rest of Western Europe
-
Eastern Europe
- Russia
- Poland
- Czech Republic
- Rest of Eastern Europe
-
East Asia
- China
- Japan
- South Korea
- Rest of East Asia
-
South Asia & Pacific
- India
- ASEAN
- Australia
- Rest of South Asia & Pacific
-
MEA
- GCC Countries
- South Africa
- Turkiye
- Rest of MEA
-
Bibliography
- Food and Agriculture Organization (FAO). (2025). The State of Food Security and Nutrition: Role of Animal Disease Control. FAO.
- International Alliance for Biological Standardization (IABS). (2024). Advances in Poultry Vaccine Technology and Standardization. IABS Proceedings.
- World Organisation for Animal Health (WOAH). (2024). Terrestrial Animal Health Code: Chapters on Newcastle Disease and Avian Influenza.
- World Veterinary Poultry Association (WVPA). (2025). Global Trends in Poultry Health Management and Vaccination. WVPA Congress Report.
Table of Content
- Executive Summary
- Global Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Product
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Product, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Product, 2026 to 2036
- Live attenuated vaccines
- Inactivated vaccines
- Recombinant vaccines
- Live attenuated vaccines
- Y to o to Y Growth Trend Analysis By Product, 2021 to 2025
- Absolute $ Opportunity Analysis By Product, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Application
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Application, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2026 to 2036
- Newcastle disease
- Avian influenza
- Infectious bursal disease
- Others
- Newcastle disease
- Y to o to Y Growth Trend Analysis By Application, 2021 to 2025
- Absolute $ Opportunity Analysis By Application, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End User
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By End User, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By End User, 2026 to 2036
- Integrated poultry farms
- Commercial hatcheries
- Veterinary service providers
- Integrated poultry farms
- Y to o to Y Growth Trend Analysis By End User, 2021 to 2025
- Absolute $ Opportunity Analysis By End User, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East & Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- USA
- Canada
- Mexico
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Brazil
- Chile
- Rest of Latin America
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- China
- Japan
- South Korea
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Key Countries Market Analysis
- USA
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- UK
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Australia & New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Russia
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Kingdom of Saudi Arabia
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Turkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- USA
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Product
- By Application
- By End User
- Competition Analysis
- Competition Deep Dive
- Zoetis Inc.
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Boehringer Ingelheim Animal Health
- Ceva Santé Animale
- Elanco Animal Health
- Phibro Animal Health Corporation
- Others
- Zoetis Inc.
- Competition Deep Dive
- Assumptions & Acronyms Used
- Research Methodology
List Of Table
- Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
- Table 2: Global Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 3: Global Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 4: Global Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 5: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 6: North America Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 7: North America Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 8: North America Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 9: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 10: Latin America Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 11: Latin America Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 12: Latin America Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 13: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 14: Western Europe Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 15: Western Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 16: Western Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 17: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 18: Eastern Europe Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 19: Eastern Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 20: Eastern Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 21: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 22: East Asia Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 23: East Asia Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 24: East Asia Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 25: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 26: South Asia and Pacific Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 27: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 28: South Asia and Pacific Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 29: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 30: Middle East & Africa Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 31: Middle East & Africa Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 32: Middle East & Africa Market Value (USD Million) Forecast by End User, 2021 to 2036
List Of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2021 to 2036
- Figure 3: Global Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 4: Global Market Y to o to Y Growth Comparison by Product, 2026 to 2036
- Figure 5: Global Market Attractiveness Analysis by Product
- Figure 6: Global Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 7: Global Market Y to o to Y Growth Comparison by Application, 2026 to 2036
- Figure 8: Global Market Attractiveness Analysis by Application
- Figure 9: Global Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 10: Global Market Y to o to Y Growth Comparison by End User, 2026 to 2036
- Figure 11: Global Market Attractiveness Analysis by End User
- Figure 12: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
- Figure 13: Global Market Y to o to Y Growth Comparison by Region, 2026 to 2036
- Figure 14: Global Market Attractiveness Analysis by Region
- Figure 15: North America Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 16: Latin America Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 17: Western Europe Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 18: Eastern Europe Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 19: East Asia Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 20: South Asia and Pacific Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 21: Middle East & Africa Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 22: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 23: North America Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 24: North America Market Y to o to Y Growth Comparison by Product, 2026 to 2036
- Figure 25: North America Market Attractiveness Analysis by Product
- Figure 26: North America Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 27: North America Market Y to o to Y Growth Comparison by Application, 2026 to 2036
- Figure 28: North America Market Attractiveness Analysis by Application
- Figure 29: North America Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 30: North America Market Y to o to Y Growth Comparison by End User, 2026 to 2036
- Figure 31: North America Market Attractiveness Analysis by End User
- Figure 32: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 33: Latin America Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 34: Latin America Market Y to o to Y Growth Comparison by Product, 2026 to 2036
- Figure 35: Latin America Market Attractiveness Analysis by Product
- Figure 36: Latin America Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 37: Latin America Market Y to o to Y Growth Comparison by Application, 2026 to 2036
- Figure 38: Latin America Market Attractiveness Analysis by Application
- Figure 39: Latin America Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 40: Latin America Market Y to o to Y Growth Comparison by End User, 2026 to 2036
- Figure 41: Latin America Market Attractiveness Analysis by End User
- Figure 42: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 43: Western Europe Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 44: Western Europe Market Y to o to Y Growth Comparison by Product, 2026 to 2036
- Figure 45: Western Europe Market Attractiveness Analysis by Product
- Figure 46: Western Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 47: Western Europe Market Y to o to Y Growth Comparison by Application, 2026 to 2036
- Figure 48: Western Europe Market Attractiveness Analysis by Application
- Figure 49: Western Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 50: Western Europe Market Y to o to Y Growth Comparison by End User, 2026 to 2036
- Figure 51: Western Europe Market Attractiveness Analysis by End User
- Figure 52: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 53: Eastern Europe Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 54: Eastern Europe Market Y to o to Y Growth Comparison by Product, 2026 to 2036
- Figure 55: Eastern Europe Market Attractiveness Analysis by Product
- Figure 56: Eastern Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 57: Eastern Europe Market Y to o to Y Growth Comparison by Application, 2026 to 2036
- Figure 58: Eastern Europe Market Attractiveness Analysis by Application
- Figure 59: Eastern Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 60: Eastern Europe Market Y to o to Y Growth Comparison by End User, 2026 to 2036
- Figure 61: Eastern Europe Market Attractiveness Analysis by End User
- Figure 62: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 63: East Asia Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 64: East Asia Market Y to o to Y Growth Comparison by Product, 2026 to 2036
- Figure 65: East Asia Market Attractiveness Analysis by Product
- Figure 66: East Asia Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 67: East Asia Market Y to o to Y Growth Comparison by Application, 2026 to 2036
- Figure 68: East Asia Market Attractiveness Analysis by Application
- Figure 69: East Asia Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 70: East Asia Market Y to o to Y Growth Comparison by End User, 2026 to 2036
- Figure 71: East Asia Market Attractiveness Analysis by End User
- Figure 72: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 73: South Asia and Pacific Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 74: South Asia and Pacific Market Y to o to Y Growth Comparison by Product, 2026 to 2036
- Figure 75: South Asia and Pacific Market Attractiveness Analysis by Product
- Figure 76: South Asia and Pacific Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 77: South Asia and Pacific Market Y to o to Y Growth Comparison by Application, 2026 to 2036
- Figure 78: South Asia and Pacific Market Attractiveness Analysis by Application
- Figure 79: South Asia and Pacific Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 80: South Asia and Pacific Market Y to o to Y Growth Comparison by End User, 2026 to 2036
- Figure 81: South Asia and Pacific Market Attractiveness Analysis by End User
- Figure 82: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 83: Middle East & Africa Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 84: Middle East & Africa Market Y to o to Y Growth Comparison by Product, 2026 to 2036
- Figure 85: Middle East & Africa Market Attractiveness Analysis by Product
- Figure 86: Middle East & Africa Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 87: Middle East & Africa Market Y to o to Y Growth Comparison by Application, 2026 to 2036
- Figure 88: Middle East & Africa Market Attractiveness Analysis by Application
- Figure 89: Middle East & Africa Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 90: Middle East & Africa Market Y to o to Y Growth Comparison by End User, 2026 to 2036
- Figure 91: Middle East & Africa Market Attractiveness Analysis by End User
- Figure 92: Global Market - Tier Structure Analysis
- Figure 93: Global Market - Company Share Analysis
- FAQs -
How big is the poultry vaccines market in 2026?
The global poultry vaccines market is estimated to be valued at USD 7.4 billion in 2026.
What will be the size of poultry vaccines market in 2036?
The market size for the poultry vaccines market is projected to reach USD 16.6 billion by 2036.
How much will be the poultry vaccines market growth between 2026 and 2036?
The poultry vaccines market is expected to grow at a 8.4% CAGR between 2026 and 2036.
What are the key product types in the poultry vaccines market?
The key product types in poultry vaccines market are live attenuated vaccines, inactivated vaccines and recombinant vaccines.
Which application segment to contribute significant share in the poultry vaccines market in 2026?
In terms of application, newcastle disease segment to command 26.6% share in the poultry vaccines market in 2026.
Poultry Vaccines Market